Cremers; Franciscus Peter Maria

Patent Applications and Registrations

Patent applications and USPTO patent grants for Cremers; Franciscus Peter Maria.The latest application filed is for "antisense oligonucleotides rescue aberrant splicing of abca4".

Company Profile

6.6.14

Cremers; Franciscus Peter Maria - Malden NL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Antisense oligonucleotides rescue aberrant splicing of ABCA4 App 20220290154 - Collin; Robert Wilhelmus Johanna ; et al.	2022-09-15
Antisense Oligonucleotides For The Treatment Of Leber Congenital Amaurosis App 20220235355 - Collin; Robert Wilhelmus Johanna ; et al.	2022-07-28
Antisense oligonucleotides for the treatment of Stargardt disease App 20220204972 - Collin; Robert Wilhelmus Johanna ; et al.	2022-06-30
Antisense oligonucleotides for the treatment of leber congenital amaurosis Grant 11,279,933 - Collin , et al. March 22, 2	2022-03-22
Antisense Oligonucleotides Rescue Aberrant Splicing of ABCA4 App 20220049250 - Collin; Robert Wilhelmus Johanna ; et al.	2022-02-17
Antisense oligonucleotides for the treatment of Stargardt disease Grant 11,236,333 - Collin , et al. February 1, 2	2022-02-01
Antisense oligonucleotides rescue aberrant splicing of ABCA4 App 20200407718 - Collin; Robert Wilhelmus Johanna ; et al.	2020-12-31
Antisense Oligonucleotides For The Treatment Of Leber Congenital Amaurosis App 20200352977 - Collin; Robert Wilhelmus Johanna ; et al.	2020-11-12
Antisense Oligonucleotides For The Treatment Of Leber Congenital Amaurosis App 20200255832 - Collin; Robert Wilhelmus Johanna ; et al.	2020-08-13
Antisense oligonucleotides for the treatment of Leber congenital amaurosis Grant 10,647,985 - Collin , et al.	2020-05-12
Antisense Oligonucleotides For The Treatment Of Stargardt Disease App 20190367919 - Collin; Robert Wilhelmus Johanna ; et al.	2019-12-05
Antisens Oligonucleotides For The Treatment Of Leber Congenital Amaurosis App 20190078091 - Collin; Robert Wilhelmus Johanna ; et al.	2019-03-14
Antisense oligonucleotides for the treatment of leber congenital amaurosis Grant 10,167,470 - Collin , et al. J	2019-01-01
Antisense Oligonucleotides For The Treatment Of Leber Congenital Amaurosis App 20180305692 - Collin; Robert Wilhelmus Johanna ; et al.	2018-10-25
Antisense Oligonucleotides For The Treatment Of Leber Congenital Amaurosis App 20180228829 - COLLIN; Robert Wilhelmus Johanna ; et al.	2018-08-16
Antisense Oligonucleotides For The Treatment Of Leber Congenital Amaurosis App 20170342414 - COLLIN; Robert Wilhelmus Johanna ; et al.	2017-11-30
Antisense oligonucleotides for the treatment of Leber congenital amaurosis Grant 9,771,580 - Collin , et al. September 26, 2	2017-09-26
Antisense Oligonucleotides For The Treatment Of Leber Congenital Amaurosis App 20140336238 - Collin; Robert Wilhelmus Johanna ; et al.	2014-11-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.